Company Earnings Update 3 minutesRegister for Free AccessCVS (CVS) 3Q17 Results: Beats on EPS, in Line on Revenues; Raises/Narrows FY17 EPS Guidance Coresight Research November 7, 2017 Executive Summary CVS Health reported 3Q17 adjusted EPS of $1.50, down 9.9% year over year and beating the $1.48 consensus estimate. Revenues were $46.2 billion, up 3.5% year over year and in line with the consensus estimate. Pharmacy Services was the faster-growing segment, with revenues up 8.1% year over year, to $32.9 billion. Revenues in the Retail/LTC (Long-Term Care) segment declined by 2.7%, to $19.6 billion. The company narrowed and raised the midpoint of its FY17 adjusted EPS guidance to $5.87–$5.91 from $5.83–$5.93 previously. Already a subscriber? Log in You are currently viewing a preview of this report. Please select an access option to view the full report. Hide Options - Show Options + Get unlimited access to all our research with one of our subscription plans. View Subscription Plans or Contact us to purchase this report. Contact us ✕ This document was generated for Other research you may be interested in: Next-Generation Product Information Management: From Spreadsheets to AIPowering the Retail Revolution with AIApril 2023 UK Retail Sales: Online Sales Slow While Total Retail Sales AccelerateData Dive: The Grocery-Store Categories Where US Shoppers Are Cutting Purchases the Most